Thermo Fisher Scientific is here to help you accelerate gene therapy development. We offer high-quality solutions, regulatory documentation and support, and access to expert consultation—allowing for a seamless transition from process development to commercialization.

To learn more about how we can help, watch our on-demand webinar, “Global Regulators’ FAQs on CMC in IND/BLA Filing: A Retrospective Look at Past Mycoplasma Validation Queries and Responses”. In this webinar, we take a retrospective look at some of the commonly asked regulator’s questions regarding mycoplasma testing and validation and recommend responses.

To view on-demand, complete the form below:

(*Indicates a mandatory field)